Cite

HARVARD Citation

    Choi, J. et al. (2021). Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma. Oncoimmunology. p. . [Online]. 
  
Back to record